JP2022547832A5 - - Google Patents

Info

Publication number
JP2022547832A5
JP2022547832A5 JP2022513622A JP2022513622A JP2022547832A5 JP 2022547832 A5 JP2022547832 A5 JP 2022547832A5 JP 2022513622 A JP2022513622 A JP 2022513622A JP 2022513622 A JP2022513622 A JP 2022513622A JP 2022547832 A5 JP2022547832 A5 JP 2022547832A5
Authority
JP
Japan
Prior art keywords
mirna
hsa
mir
stem cells
pluripotent stem
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022513622A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022547832A (ja
JP7876440B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/048080 external-priority patent/WO2021041592A1/en
Publication of JP2022547832A publication Critical patent/JP2022547832A/ja
Publication of JP2022547832A5 publication Critical patent/JP2022547832A5/ja
Application granted granted Critical
Publication of JP7876440B2 publication Critical patent/JP7876440B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022513622A 2019-08-28 2020-08-27 血管疾患の処置方法 Active JP7876440B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962892712P 2019-08-28 2019-08-28
US62/892,712 2019-08-28
PCT/US2020/048080 WO2021041592A1 (en) 2019-08-28 2020-08-27 Methods of treating vascular diseases

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2026080664A Division JP2026133498A (ja) 2019-08-28 2026-05-13 血管疾患の処置方法

Publications (3)

Publication Number Publication Date
JP2022547832A JP2022547832A (ja) 2022-11-16
JP2022547832A5 true JP2022547832A5 (cg-RX-API-DMAC7.html) 2023-09-04
JP7876440B2 JP7876440B2 (ja) 2026-06-19

Family

ID=72422305

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022513622A Active JP7876440B2 (ja) 2019-08-28 2020-08-27 血管疾患の処置方法

Country Status (10)

Country Link
US (1) US20220280572A1 (cg-RX-API-DMAC7.html)
EP (1) EP4022042A1 (cg-RX-API-DMAC7.html)
JP (1) JP7876440B2 (cg-RX-API-DMAC7.html)
KR (1) KR20220054359A (cg-RX-API-DMAC7.html)
CN (1) CN115003800A (cg-RX-API-DMAC7.html)
AU (1) AU2020337929B2 (cg-RX-API-DMAC7.html)
CA (1) CA3151637A1 (cg-RX-API-DMAC7.html)
IL (1) IL290892A (cg-RX-API-DMAC7.html)
TW (1) TW202122577A (cg-RX-API-DMAC7.html)
WO (1) WO2021041592A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102411018B1 (ko) 2015-08-18 2022-06-20 아스텔라스 인스티튜트 포 리제너러티브 메디슨 임상 제제
US20230027007A1 (en) * 2021-07-02 2023-01-26 Regeneron Pharmaceuticals, Inc. Treatment of Hypertension With Solute Carrier Family 9 Isoform A3 Regulatory Factor 2 (SLC9A3R2) Inhibitors
CN116832051B (zh) * 2023-07-08 2024-02-09 首都医科大学 抗氧化抗炎和促脂质代谢协同纳米给药系统

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003070083A2 (en) * 2002-02-15 2003-08-28 Cornell Research Foundation, Inc. Endothelial precursor cells for enhancing and restoring vascular function
AU2007238660C1 (en) 2006-04-14 2013-11-07 Astellas Institute For Regenerative Medicine Hemangio-colony forming cells
CN101534747A (zh) * 2006-07-10 2009-09-16 哥伦比亚大学 从组织祖细胞和血管祖细胞从头形成和再生血管化组织
BRPI0912201A2 (pt) 2008-05-06 2019-09-24 Advanced Cell Tech Inc células formadoras de colônias de hemangios e células de hemangio não enxertantes
KR101920891B1 (ko) * 2010-08-27 2018-11-21 조슈아 엠 헤어 심장 치료를 위한 골수 유래 ｃｄ271 전구 세포
PL2785359T3 (pl) 2011-11-30 2018-12-31 Astellas Institute For Regenerative Medicine Mezenchymalne komórki zrębowe i związane z nimi zastosowania
US9428732B2 (en) * 2011-12-05 2016-08-30 Primorigen Biosciences, Inc. Compositions and methods for differentiating pluripotent stem cells into primitive blood cells and uses thereof
JP6746313B2 (ja) * 2012-08-01 2020-08-26 ユナイテッド セラピューティクス コーポレイション プロスタサイクリン処理された内皮前駆細胞による肺動脈性高血圧症の処置
CA2896053A1 (en) * 2012-12-21 2014-06-26 Ocata Therapeutics, Inc. Methods for production of platelets from pluripotent stem cells and compositions thereof
EP2970912B1 (en) * 2013-03-13 2019-03-06 Wisconsin Alumni Research Foundation Methods and materials for hematoendothelial differentiation of human pluripotent stem cells under defined conditions
CA2930304A1 (en) * 2013-11-13 2015-05-21 Cornell University Post-natal hematopoeitic endothelial cells and their isolation and use
US10626372B1 (en) * 2015-01-26 2020-04-21 Fate Therapeutics, Inc. Methods and compositions for inducing hematopoietic cell differentiation
KR102411018B1 (ko) 2015-08-18 2022-06-20 아스텔라스 인스티튜트 포 리제너러티브 메디슨 임상 제제
EP3383182B1 (en) * 2015-12-03 2023-06-07 The Brigham and Women's Hospital, Inc. Methods for generating functional hematopoietic stem cells
US11345895B2 (en) * 2016-11-18 2022-05-31 Wisconsin Alumni Research Foundation Induction of arterial-type of hemogenic endothelium (AHE) and enhancement of T cell production from PSCs through overexpression of ETS factors or modulating MAPK/ERK signalling pathways

Similar Documents

Publication Publication Date Title
ES2602474T3 (es) Angiogénesis que usa células madre placentarias
EP2367932B1 (en) Amnion derived adherent cells
JP2010540530A5 (cg-RX-API-DMAC7.html)
JP2006521121A5 (cg-RX-API-DMAC7.html)
CN114224916B (zh) 用于治疗心力衰竭的方法
CN107206027A (zh) 进行性心力衰竭的预防
JP2022545737A5 (cg-RX-API-DMAC7.html)
KR20220054359A (ko) 혈관 질병을 치료하는 방법
Goushki et al. Applications of extraembryonic tissue-derived cells in vascular tissue regeneration
Loomans et al. Is endothelial progenitor cell dysfunction involved in altered angiogenic processes in patients with hypertension?
El-Derby et al. Adult stem cells: mesenchymal stromal cells, endothelial progenitor cells, and pericytes
JP2017530954A5 (cg-RX-API-DMAC7.html)
JP2019533691A5 (cg-RX-API-DMAC7.html)
Hsu et al. Challenges and Perspectives on the Use of Pericytes in Tissue Engineering
Gambini et al. Angiogenic and reparative potency of a human cardiac CD90− mesenchymal subpopulation in heart ischemic model
Weng et al. The effect of allogeneic cardiac stem cells in left ventricular geometry and function in a rat model of myocardial infarction
Pugliatti et al. Non compaction cardiomyopathy and Antiphospholipid syndrome: A catastrophic thromboembolic association
WO2010136212A1 (en) Lipoxygenase and its use in wound healing
Lebrun et al. Improvement of exercise-induced cardiac deformation after cell therapy for severe chronic ischemic heart failure
Poellinger Mechanisms of gene regulation in hypoxia: Role of hypoxia-inducible factors in regulation of the epigenetic landscape of target cells
CA2971514C (en) Prevention of progressive heart failure
Flam et al. SHOULD WE AVOID BLOCKING THE RENIN-ANGIOTENSIN SYSTEM IN PATIENTS WITH AORTIC STENOSIS? A SYSTEMATIC REVIEW: PP. 23.217
JP2010213576A (ja) Ｐ１９ｃｌ６のクローン細胞と心筋細胞への分化誘導方法
Yuasa et al. Zac1 is an essential transcription factor for cardiac morphogenesis and cardiac myocyte apoptosis inhibition
KR20210099527A (ko) 줄기세포를 포함하는 심막 내 주입용 조성물 및 이의 용도